Evaluation and Feedback. Tempus shall consider in good faith any feedback proposed by GSK related to Tempus’s design decisions in connection its evaluation and development of multimodal datasets covering new therapeutic areas, geographies or demographics that would impact the scope of the Data Licensing Services available to GSK under this Agreement.
Appears in 2 contracts
Sources: Strategic Collaboration Agreement (Tempus AI, Inc.), Strategic Collaboration Agreement (Tempus Labs, Inc.)